A 'universal' vaccine that could revolutionise the treatment of cancer could be available in just two years.
The TeloVac jab is part of a new generation of drugs that use the body’s own defences to fight the disease, stopping tumours in their tracks.
TeloVac has already been given to hundreds of Britons with pancreatic cancer, one of the deadliest forms of the disease.
Комментариев нет:
Отправить комментарий